Avicenna Alliance to develop Public Private Partnership on in silico medicine

The Avicenna Alliance has been given the green light by the European Commission to pursue the creation of a Public Private Partnership (PPP) on in silico medicine.
Promoting in silico medicine

The Avicenna Alliance is currently engaged in outreach with a multitude of organisations with an interest in in silico technologies to pursue the creation of a PPP. The development of a PPP is the primary activity of the Avicenna Alliance for its 1st year and aims to create new funding streams for in silico projects across Europe.

The Alliance will be in continuous contact with the European Commission to ensure the maximum value of this PPP.

For more information on the Avicenna Alliance click here


Gallery:

Promoting in silico medicine

Date: 26/02/2015 | Tag: | News: 358 of 566
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Are you...

A clinician?
A researcher?
A science curious?
An industrial?

Open subscribe

ARCHIVE

Read all the newsletters of the VPH Institute

GO